One direct-acting anticoagulant stands out as the least likely to cause dangerous bleeding in elderly patients with atrial fibrillation, according to a new study. But other new research questions the ...
Patients with atrial fibrillation receiving routine medical care within a large managed care organization were found to have suboptimal anticoagulation control. Retrospective cross-sectional study of ...
MedPage Today on MSN
Postop Afib Scare Fades With Greater Scrutiny
New-onset atrial fibrillation (Afib or AF) was surprisingly common after coronary artery bypass grafting (CABG), but its ...
Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.
Objective: To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF), in particular those at risk of falls. Data Sources: Primary literature was identified ...
Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study.
For patients who are scheduled for surgery, warfarin therapy should be discontinued 5 to 6 days before the procedure. 26 In patients who are at high risk for developing blood clots, the clinician may ...
As one of the most powerful independent risk factors for ischemic stroke and the most clinically relevant arrhythmia, atrial fibrillation (AF) poses a serious clinical and public health threat as the ...
NOAH-AFNET 6 trial: Oral anticoagulation not recommended for patients with atrial high rate episodes
Blood thinners (anticoagulants) cause bleeding without preventing stroke in patients with atrial high rate episodes (AHRE), but without electrocardiogram (ECG)-diagnosed atrial fibrillation, according ...
MedPage Today on MSN
Anticoagulant Alone Safer in Stroke Patients With Afib and Atherosclerosis
The Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis (ATIS-NVAF) trial included 316 patients from 41 centers in Japan. Mean age was 77.2 ...
The net clinical benefit of anticoagulants for atrial fibrillation (AF) – one of the most important causes of irregular heartbeats and a leading cause of stroke – decreases with age, as the risk of ...
Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that significantly elevates the risk of thromboembolic events, most notably ischaemic stroke. Anticoagulation therapy has long been a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results